This is not the most recent version of the article. View current version (6 MAY 2014)
Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders
Editorial Group: Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
Published Online: 11 JUL 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Regan J, Walshe M, Murphy A, McMahon BP, Coughlan T. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009968. DOI: 10.1002/14651858.CD009968.
- Publication Status: New
- Published Online: 11 JUL 2012
This is not the most recent version of the article. View current version (06 MAY 2014)
This is the protocol for a review and there is no abstract. The objectives are as follows:
- To establish the efficacy and safety of botulinum toxin aimed at improving UOS dysfunction in people with non progressive and progressive neurological disease.
- To provide the best evidence to inform clinical practice.
- To assist with future research planning.